NCT00345150
|
|
Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
|
Phase 1
|
Completed
|
NCT00344916
|
|
Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
|
Phase 1
|
Completed
|
NCT00005107
|
|
Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia
|
Phase 1
|
Recruiting
|
NCT00345137
|
|
Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis
|
Phase 1
|
Completed
|
NCT00344734
|
|
Effects of Acute L-NMMA Treatment on Renal Hemodynamics and Vasoactive Hormones in Patients With Congestive Heart Failure
|
Phase 1
|
Completed
|
NCT02388178
|
2015-04-01 |
To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study
|
Phase 2
|
Not Yet Recruiting
|
NCT02291458
|
2014-11-01 |
L-arginine and Brown Adipose Tissue
|
Phase 3
|
Recruiting
|
NCT01607879
|
2014-03-01 |
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
|
Phase 2
|
Recruiting
|
NCT02017249
|
2014-03-01 |
Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
|
Phase 1
|
Recruiting
|
NCT01855334
|
2013-09-01 |
L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
|
Phase 4
|
Withdrawn
|
NCT01841281
|
2013-08-01 |
L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels
|
Phase 2
|
Recruiting
|
NCT02245165
|
2013-06-01 |
Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades
|
Phase 1
|
Completed
|
NCT01860911
|
2013-04-01 |
Plasma Triglyceride Extraction by The Muscle
|
Phase 1
|
Recruiting
|
NCT01791816
|
2013-02-01 |
Mechanisms of Vasovagal Syncope
|
Phase 0
|
Recruiting
|
NCT01710371
|
2012-12-01 |
Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
|
Phase 1
|
Recruiting
|
NCT01423799
|
2012-07-01 |
Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment
|
Phase 3
|
Recruiting
|
NCT01603446
|
2012-05-01 |
L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome
|
Phase 2
|
Completed
|
NCT01482247
|
2012-04-01 |
L-Arginine, Vascular Response and Mechanisms
|
Phase 2
|
Completed
|
NCT01388764
|
2012-01-01 |
Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids
|
Phase 1
|
Completed
|
NCT02009527
|
2012-01-01 |
Arginase Inhibition in Ischemia-reperfusion Injury
|
Phase 1
|
Recruiting
|
NCT01439555
|
2011-11-01 |
Endothelial Facilitation in Alzheimer's Disease
|
Phase 2
|
Recruiting
|
NCT01118520
|
2011-09-01 |
Evaluation of Effect of Angiotensin-converting Enzyme (ACE) Inhibitors on Small Aneurysm Growth Rate
|
Phase 4
|
Recruiting
|
NCT01485757
|
2011-07-01 |
Prospective L-arginine Study
|
Phase 1
|
Terminated
|
NCT01287585
|
2011-07-01 |
Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy
|
Phase 3
|
Active, Not Recruiting
|
NCT01263041
|
2011-05-01 |
Effect of L-arginine and Glutamine on Preterm
|
Phase 2/Phase 3
|
Completed
|
NCT01324115
|
2011-04-01 |
NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
|
Phase 1
|
Terminated
|
NCT01266018
|
2010-12-01 |
Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer
|
Phase 2
|
Active, Not Recruiting
|
NCT01105130
|
2010-10-01 |
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors
|
Phase 2
|
Completed
|
NCT02363348
|
2010-08-01 |
Efficacy and Safety of L Arginine to Prevent Preeclampsia
|
Phase 3
|
Completed
|
NCT01070940
|
2010-02-01 |
L-NMMA Dose-response Study in Healthy Subjects
|
Phase 1
|
Completed
|
NCT01052623
|
2010-01-01 |
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
|
Phase 4
|
Recruiting
|
NCT01038622
|
2009-11-01 |
Directed Immuno Nutrition by L-arginine for Critically Ill Patients
|
Phase 4
|
Completed
|
NCT00848302
|
2009-09-01 |
Endothelial Function in Human Arteries
|
Phase 1
|
Completed
|
NCT00856817
|
2009-03-01 |
Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation
|
Phase 4
|
Terminated
|
NCT00995839
|
2008-11-01 |
Terlipressin in Septic Shock: Effects on Microcirculation
|
Phase 2/Phase 3
|
Completed
|
NCT00785811
|
2008-10-01 |
Effect of Chronic Supplementation of L-arginine in the Muscular Performance
|
Phase 4
|
Terminated
|
NCT00917826
|
2008-09-01 |
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
|
Phase 2
|
Terminated
|
NCT00677339
|
2008-06-01 |
L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)
|
Phase 3
|
Completed
|
NCT00616304
|
2008-02-01 |
Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria
|
Phase 2
|
Suspended
|
NCT00345605
|
2008-02-01 |
Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
|
Phase 2
|
Completed
|
NCT00406731
|
2008-01-01 |
Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure
|
Phase 2
|
Withdrawn
|
NCT00571766
|
2007-11-01 |
Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy
|
Phase 3
|
Completed
|
NCT00974714
|
2007-09-01 |
L-arginine Effects on Chronic Hypertension in Pregnancy
|
Phase 3
|
Completed
|
NCT00490100
|
2007-06-01 |
Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
|
Phase 1/Phase 2
|
Completed
|
NCT01682889
|
2007-01-01 |
The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation
|
Phase 4
|
Completed
|
NCT00753948
|
2006-12-01 |
Exhaled Levels of Nitric Oxide
|
Phase 2/Phase 3
|
Completed
|
NCT00405665
|
2006-11-01 |
The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis
|
Phase 2
|
Completed
|
NCT01142219
|
2006-09-01 |
L-Arginine and Sickle Cell Disease
|
Phase 3
|
Completed
|
NCT01742702
|
2006-06-01 |
Haemodynamics in Hypertension
|
Phase 0
|
Recruiting
|
NCT00137124
|
2006-05-01 |
L-Arginine Metabolism in Essential Hypertension
|
Phase 2/Phase 3
|
Completed
|
NCT00200746
|
2006-04-01 |
Treatment of Alcohol-Related Hepatitis With Arginine
|
Phase 2
|
Withdrawn
|
NCT00917449
|
2005-12-01 |
Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome
|
Phase 3
|
Completed
|
NCT02117206
|
2005-11-01 |
Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans
|
Phase 4
|
Completed
|
NCT00708357
|
2005-05-01 |
Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?
|
Phase 0
|
Terminated
|
NCT00264706
|
2005-03-01 |
PolyArginine Treated vEiN grafTs (PATENT)
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
NCT00147368
|
2005-02-01 |
Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria
|
Phase 1/Phase 2
|
Completed
|
NCT00569465
|
2005-01-01 |
N-Acetylcysteine and Arginine Administration in Diabetic Patients
|
Phase 4
|
Terminated
|
NCT00410085
|
2005-01-01 |
Renal Hemodynamics and Tubular Function in Patients With Obstructive Sleep Apnea and Healthy Controls
|
Phase 4
|
Completed
|
NCT00280683
|
2004-12-01 |
Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma
|
Phase 2
|
Completed
|
NCT00134433
|
2004-11-01 |
Endothelial Modulation for Angiogenic Therapy
|
Phase 1/Phase 2
|
Completed
|
NCT00408577
|
2004-11-01 |
Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.
|
Phase 3
|
Completed
|
NCT00513617
|
2004-06-01 |
Effectiveness of Arginine as a Treatment for Sickle Cell Anemia
|
Phase 2
|
Completed
|
NCT00127907
|
2004-05-01 |
Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest
|
Phase 4
|
Completed
|
NCT00047983
|
2004-04-01 |
Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients
|
Phase 0
|
Completed
|
NCT00213915
|
2004-02-01 |
L-Arginine Supplementation and Exercise; L-Arginine Supplementation and Renal Function
|
Phase 4
|
Completed
|
NCT01775020
|
2003-10-01 |
Dose-response Study of Arginine Supplementation in Severe Sepsis
|
Phase 0
|
Completed
|
NCT00777075
|
2003-07-01 |
L-Arginine and Erectile Dysfunction
|
Phase 4
|
Completed
|
NCT00902616
|
2003-06-01 |
Effect of Arginine on Microcirculation in Patients With Diabetes
|
Phase 4
|
Completed
|
NCT00237770
|
2003-06-01 |
Prevention of Low Blood Pressure in Persons With Tetraplegia
|
Phase 2/Phase 3
|
Completed
|
NCT00056433
|
2003-03-01 |
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
|
Phase 1
|
Completed
|
NCT00157521
|
2002-09-01 |
L-Arginine in Pre-Eclampsia
|
Phase 3
|
Completed
|
NCT00431392
|
2001-09-01 |
Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions
|
Phase 2
|
Completed
|
NCT00029731
|
2001-08-01 |
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
|
Phase 2
|
Completed
|
NCT00223717
|
2001-06-01 |
Treatment of Supine Hypertension in Autonomic Failure
|
Phase 1/Phase 2
|
Recruiting
|
NCT00134420
|
2001-02-01 |
Growth Hormone and Chromosome 18q- and Abnormal Growth
|
Phase 3
|
Active, Not Recruiting
|
NCT00469846
|
2001-01-01 |
L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
|
Phase 2
|
Terminated
|
NCT01796678
|
2000-09-01 |
Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial
|
Phase 2
|
Completed
|
NCT00006136
|
1999-03-01 |
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
|
Phase 2
|
Completed
|
NCT00001752
|
1998-09-01 |
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
|
Phase 2
|
Completed
|
NCT00004412
|
1997-09-01 |
Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
|
Phase 2
|
Recruiting
|
NCT00006340
|
1994-12-01 |
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
|
Phase 1
|
Completed
|